➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:


Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Details for Patent: 7,381,427

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,381,427 protect, and when does it expire?

Patent 7,381,427 protects ESKATA and is included in one NDA.

This patent has fourteen patent family members in thirteen countries.

Summary for Patent: 7,381,427
Title:Seborrheic keratosis treatment
Abstract: The subject of the present invention is seborrheic keratosis removal and prevention utilizing safe dependable effective biocompatible treatments with no scarring, bleeding, burning, freezing, shocking, and hypopigmentation or hyperpigmentation.
Inventor(s): Ancira; Margaret (Phoenix, AZ), Miller; Mickey (Paradise Valley, AZ)
Assignee: Miller; Mickey (Paradise Valley, AZ)
Application Number:10/684,136
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 7,381,427

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Aclaris ESKATA hydrogen peroxide SOLUTION;TOPICAL 209305-001 Dec 14, 2017 DISCN Yes No   Try Before You Buy   Try Before You Buy TREATMENT OF SEBORRHEIC KERATOSES THAT ARE RAISED   Try Before You Buy
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,381,427

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 397452   Try Before You Buy
Australia 2007203283   Try Before You Buy
Brazil 0207163   Try Before You Buy
Canada 2437823   Try Before You Buy
China 100508990   Try Before You Buy
China 1501804   Try Before You Buy
Germany 60226953   Try Before You Buy
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.